Avastin Cancer Drug Linked To Anemia In Combo Trials Doctors Warned

On Monday, the US Food and Drug Administration (FDA) posted on its website, a copy of a letter from Genentech Inc, the makers of cancer drug Avastin, to healthcare providers that warns them about a type anemia seen in clinical trial patients treated with Avastin in combination with Pfizer Inc’s Sutent (sunitinib malate).

More: continued here

Filed under: Cancer on July 16th, 2008